Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 2, Number 3—July 1996

Dispatch

A Highly Heterogeneous HIV-1 Epidemic in the Central African Republic

Marcel Massanga*, Justin Ndoyo*, Dale J. Hu†, Chou-Pong Pau†, Stephanie Lee-Thomas†, Reginald Hawkins†, Dominique Senekian*, Mark A. Rayfield†, J. Richard George†, Amédée Zengais*, Noel Ngalla Yatere*, Victor Yossangang*, Aliou Samori*, Gerald Schochetman†, and Timothy J. Dondero†
Author affiliations: *Ministère de la Santé Publique et de la Population, Central African Republic; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 2

Serotype distribution among 173 HIV-1-infected persons. Letters indicate serologic reactivities to peptides to the given HIV-1 subtypes A-F. Sera reactive to two different subtype peptides are given as a combination of two letters. Multiple refers to sera that reacted to more than two different subtype peptides. Nonreactive refers to sera that did not react to any of the peptides used.

Figure 2. Serotype distribution among 173 HIV-1-infected persons. Letters indicate serologic reactivities to peptides to the given HIV-1 subtypes A-F. Sera reactive to two different subtype peptides are given as a combination of two letters. Multiple refers to sera that reacted to more than two different subtype peptides. Nonreactive refers to sera that did not react to any of the peptides used.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO